Follow the link below to read the letter sent to the Acting Director of National Institutes of Health (NIH) and the Director of National Cancer Institute (NCI) regarding the increase in funding to NIH through the American Recovery and Reinvestment Act of 2009:
http://www.lungcanceralliance.org/washingtonbriefNIHNCIletter2_27_09.html
Friday, February 27, 2009
Weekly News for 4/23/09
Terminal lung cancer patients are living longer thanks to the world's first registered lung cancer vaccine, a leading Cuban scientist says.
Sputum cytology and bronchoscopyexaminations could help detecting early central airway lung cancer, researchers of the University of Hong Kong said here Tuesday.
Europeans with the least education have a higher incidence of lung cancer compared with those with the highest education. However, smoking history accounts for approximately half of this risk, according to a new study.
John Updike, the kaleidoscopically gifted writer whose quartet of Rabbit Angstrom novels highlighted so vast and protean a body of fiction, verse, essays and criticism as to earn him comparisons with Henry James and Edmund Wilson among American men of letters, died Tuesday. He was 76 and lived in Beverley Farms. Massachusetts.
The cause of death was lung cancer, his publisher, Knopf, said in a statement.
Tuesday, February 24, 2009
Tuesday, February 17, 2009
Weekly News for 4/16/09
The active ingredient in marijuana cuts tumor growth in common lung cancer in half and significantly reduces the ability of the cancer to spread, say researchers at Harvard University who tested the chemical in both lab and mouse studies.
“This is the second study to show that people with lung cancer who took the daily pill Tarceva following initial treatment lived longer without their cancer getting worse. We plan to discuss these data with the FDA to determine next steps,” said Hal Barron, M.D., Genentech's senior vice president, development and chief medical officer. “Tumors use different pathways to grow and these results showed that combining medicines targeting two of these pathways instead of one delayed disease progression.”
Did you know that there is a relationship between COPD and lung cancer? And that this relationship, according to a recent study in the European Respiratory Journal is independent of past smoking history?
Now recovering from surgery to remove cancer from his lung, Adams, 59, is crediting his eight-year-old feline friend Tiger for alerting him and his family doctor to a mass in his lung.
Cancer Research UK analysis suggests that by 2024, 40 per 100,000 people will get the cancer compared with the current rate of 50 per 100,000.
In more health stories this week, experts test whether mushrooms could stop cancer coming back and hopes that a new stem cell therapy could reverse a deadly lung disease.
Wednesday, February 4, 2009
Weekly News for 4/2/09
This morning I did a search via Twitter of posts with the words "Lung Cancer". Below are some highlights of my findings:
"Lung cancer, the deadliest cancer for both men and women, claims more lives than colon, breast and prostate cancers combined. Often the disease does not cause any early symptoms, making diagnosis difficult at a treatable stage. Consequently, more patients are treated for advanced lung cancer than for early stage disease.
The Mary Babb Randolph Cancer Center at West Virginia University is among 12 facilities nationwide offering a Phase II clinical trial to assess a new combination therapy for advanced non-small cell lung cancer (NSCLC) in patients who have never received chemotherapy."
"On The Path Productions LLC, a San Francisco health media company, is spreading the word about lung cancer research and its need for funding. In conjunction with the Bonnie J. Addario Lung Cancer Foundation, On the Path (OPP) has produced and aired the national Life Love & Health: Special Edition program, examining the stigma associated with this so-called "smokers' disease" and how it may be hindering a search for the cure."
"...clinical trial of the drug Tarceva in lung cancer patients was halted early because the treatment significantly extended the time patients lived without their disease worsening. The report sent OSI shares 16 percent higher, the biggest single-day gain in more than four years."
"Survey led by Fox Chase Cancer Center researcher shows how moderate exercise a few times a week might improve the mental and physical health of lung cancer survivors..."
"An Australian-first research project is hoping the use of a more delicate screening process to help boost early detection of lung cancer."
"Cuba has approved what is believed to be the world's first registered lung cancer vaccine and is offering it to Cuban and foreign patients in its hospitals."
"Preliminary Data Show Seven of 17 Evaluable Patients Achieved an Objective Tumor Response by End of Four Treatment Cycles."
"A late-stage trial found that combining Genentech Inc's (DNA.N) Avastin with cancer pill Tarceva, which is co-marketed with OSI Pharmaceuticals (OSIP.O), extended the time patients with advanced lung cancer lived without the disease getting worse."
Monday, February 2, 2009
Lung cancer to become major cause of mortality soon
Got this article from new friend/ally, Jennifer Windrum. Highlights below. Perhaps if it becomes the leading cause of mortality it will finally get the attention its deserved for decades.
"Lung cancer will soon become the leading cause of mortality all over the world, Dr Adnan Ali Zaidi, a well-known oncologist at the Aga Khan University Hospital (AKUH) said on Saturday. He was addressing a seminar on lung cancer organized by the Seminar Committee at the University of Karachi (KU) Faculty of Pharmacy, in collaboration with Roche Pakistan Ltd...
Dr Zaidi said that 70 percent of lung cancer patients die within a year..."
Subscribe to:
Posts (Atom)